Definitive Healthcare (NASDAQ:DH) Stock Price Up 4.9%

Definitive Healthcare Corp. (NASDAQ:DH)’s share price was up 4.9% during mid-day trading on Tuesday . The stock traded as high as $6.02 and last traded at $6.00. Approximately 72,200 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 695,588 shares. The stock had previously closed at $5.72.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on DH shares. Morgan Stanley cut shares of Definitive Healthcare from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $11.50 to $9.00 in a report on Wednesday, May 8th. William Blair reiterated an “outperform” rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Wednesday, May 8th. Stifel Nicolaus reduced their price target on shares of Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Finally, Barclays reduced their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, May 9th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Definitive Healthcare currently has a consensus rating of “Hold” and a consensus target price of $9.56.

Definitive Healthcare Stock Performance

The company has a market cap of $702.86 million, a PE ratio of -3.41, a P/E/G ratio of 4.36 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30. The stock’s 50-day simple moving average is $5.53 and its 200 day simple moving average is $7.24.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The firm had revenue of $63.48 million for the quarter, compared to analysts’ expectations of $64.00 million. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. As a group, equities analysts anticipate that Definitive Healthcare Corp. will post 0.1 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

A number of large investors have recently made changes to their positions in DH. Tower Research Capital LLC TRC increased its holdings in shares of Definitive Healthcare by 599.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock valued at $58,000 after purchasing an additional 4,959 shares in the last quarter. Norden Group LLC acquired a new stake in Definitive Healthcare in the 1st quarter valued at about $83,000. Berry Wealth Group LP acquired a new stake in Definitive Healthcare in the 1st quarter valued at about $99,000. Susquehanna Fundamental Investments LLC acquired a new stake in Definitive Healthcare in the 1st quarter valued at about $120,000. Finally, Hennion & Walsh Asset Management Inc. acquired a new stake in Definitive Healthcare in the 2nd quarter valued at about $127,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.